Journal of the Association of Nurses in AIDS Care
Volume 17, Issue 3 , Pages 3-17 , May 2006

Coronary Heart Disease Risks and Lifestyle Behaviors in Persons With HIV Infection

References 

  1. Barbaro G , DiLorenzo G , Gianaspro G , et al.   Incidence of coronary artery disease in HIV-infected patients not on protease inhibitors (A randomized, multicenter trial) . 2002; July. (Abstract WeOrB1307). Paper presented at the XIV International AIDS Conference, Barcelona, Spain.
  2. Bergersen BM , Sandvik L , Bruun JN , Tonstad S . Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy (Results from a Norwegian study of 721 subjects) . European Journal of Clinical Microbiology and Infectious Diseases . 2004;23:625–630
  3. Bollens D , Guiguet M , Tangre P , Rachline RA , Meynard JL , Benlian P , et al.   Family history, immuno-infectious status and type of antiretroviral drug regimen are predictors for major hypertriglyceridemia in HIV infected patients . 2001; December. (Abstract No. I-220). Paper presented at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago.
  4. Bozzette SA , Joyce G , McCaffrey DF , Leibowitz AA , Morton SC , Berry SH , et al.  HIV Cost and Services Utilization Study Consortium   Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy . New England Journal of Medicine . 2001;344:817–823
  5. Brunner E , White I , Thorogood M , Bristow A , Curle D , Marmot M . Can dietary interventions change diet and cardiovascular risk factors? A meta-analysis of randomized controlled trials . American Journal of Public Health . 1997;87:1415–1422
  6. Carr A , Cooper DA . Images in clinical medicine. Lipodystrophy associated with an HIV-protease inhibitor . New England Journal of Medicine . 1998;339:1296
  7. Carr A , Emery S , Law M , Puls R , Lundgren JD , Powderly WG . An objective case definition of lipodystrophy in HIV-infected adults (A case control study) . The Lancet . 2003;361:726–735
  8. Carr A , Samaras K , Burton S , Law M , Freund J , Chisholm DJ , et al.   A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors . AIDS . 1998;12:F51–F58
  9. Carr A , Samaras K , Thorisdottir A , Kaufmann GR , Chisholm DJ , Cooper DA . Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus (A cohort study) . Lancet . 1999;353:2093–2099
  10. Chobanian AV , Bakris GL , Black HR , Cushman WC , Green LA , Izzo J , et al.   Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure . Hypertension . 2003;42:1206–1252.
  11. Chun TW , Stuyver L , Mizell SB , Ehler L , Mican JAM , Baseler M , et al.   Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy . 1997;94:13193–13197 Proceedings of the National Academy of Sciences of the United States of America
  12. Clark LT , Ferdinand KC , Flack JM , Gavin JR , Hall WD , Kumanyika SK , et al.   Coronary heart disease in African Americans . Heart Disease . 2001;3:97–108
  13. Clingerman E . Physical activity, social support, and health-related quality of life among persons with HIV disease . Journal of Community Health Nursing . 2004;21:179–197
  14. Collins RL , Kanouse DE , Gifford AL , Senterfitt JW , Schuster MA , McCaffrey DF , et al.   Changes in health-promoting behavior following diagnosis with HIV (prevalence and correlates in a national probability sample) . Health Psychology . 2001;20:351–360
  15. Currier JS , Taylor A , Boyd F , Dezii CM , Kawabata H , Burtcel B , et al.   Coronary heart disease in HIV-infected individuals . Journal of Acquired Immune Deficiency Syndromes . 2003;33:506–512
  16. d’Arminio A , Sabin CA , Phillips AN , Reiss P , Weber R , Kirk O , et al.  D:A:D Study Group   Cardio- and cerebrovascular events in HIV-infected persons . AIDS . 2004;18:1811–1817
  17. Ena J , Benito C , Llacer P , Pasquau F , Amador C . Abnormal body fat distribution and type of antiretroviral therapy as predictors of cardiovascular disease risk in HIV-infected patients . Medical Clinics . 2004;122:746–747
  18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults . Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Adults (Adult Treatment Panel III) . Journal of the American Medical Association . 2001;285:2486–2497
  19. Ferdinand KC , Clark LT . The epidemic of diabetes mellitus and the metabolic syndrome in African Americans . Reviews in Cardiovascular Medicine . 2004;5(Suppl. 3):S28–S33
  20. Ford ES , Giles WH , Mokdad AH . Increasing prevalence of the metabolic syndrome among U.S. Adults . Diabetes Care . 2004;27:2444–2449
  21. Friis-Moller N , Sabin CA , Weber R , d’Arminio MA , El-Sadr WM , Reiss P , et al.  Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group   Combination antiretroviral therapy and the risk of myocardial infarction . New England Journal of Medicine . 2003;349:993–2003
  22. Gomez AF , Romero SP , Bernal AA , Garcia-Egido MA , Escobar JJB , Lopez-Saez PR . Dyslipidemia and hyperinsulinemia in HIV patients on HAART . 2001; December (Abstract No. 222). Paper presented at the 41st Interscience Conference on Antimocribial Agents and Chemotherapy, Chicago.
  23. Gordon NF , Salmon RD , Franklin BA , Sperling LS , Hall L , Leighton RF , et al.   Effectiveness of therapeutic lifestyle changes in patients with hypertension, hyperlipidemia, and/or hyperglycemia . American Journal of Cardiology . 2004;94:1558–1561
  24. Grundy SM , Cleeman JI , Merz CNB , Brewer HB , Clark LT , Hunninghake DB , et al.  Coordinating Committee of the National Cholesterol Education Program   Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines . Journal of the American College of Cardiology . 2004;44:720–732
  25. Grunfeld C , Tien P . Difficulties in understanding the metabolic complications of acquired immune deficiency syndrome . Clinical Infectious Disease . 2003;37(Suppl. 2):S43–S46
  26. Hadigan C , Jeste S , Anderson EJ , Tsay R , Cyr H , Grinspoon S . Modifiable dietary habits and their relation to metabolic abnormalities in men and women with human immunodeficiency virus infection and fat redistribution . Clinical Infectious Disease . 2001;33:710–717
  27. Hatano H , Miller KD , Yoder CP , Yansvski JA , Sebring NG , Jones EC , et al.   Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy . AIDS . 2000;14:1935–1942
  28. Heath KV , Hogg RS , Chan KJ , Harris M , Montessori V , O’Shaughnessy MV , et al.   Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database . AIDS . 2001;15:231–239
  29. Hlatky MA , Boineau RF , Higginbotham MB , Lee KL , Mark DB , Califf RM , et al.   , A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index) . American Journal of Cardiology . 1989;64:651–654
  30. Kotler D , Rosenbaum K , Wang J , Pierson R . Studies of body composition and fat distribution in HIV-infected and control subjects . Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology . 1999;20:228–237
  31. Lowe MR , Chuck SK , Penzak SR . Efficacy and safety of Pravastatin in protease inhibitor-related hyperlipidemia (PIH) . 2001; December. (Abstract No. 228). Paper presented at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago.
  32. Nixon S , O’Brien K , Glazier RH , Wilkins AL . Aerobic exercise interventions for people with HIV/AIDS . Cochrane Database Systematic Review . 2001;1: CD001796
  33. Palella FJ , Delaney KM , Moorman AC , Loveless MO , Fuhrer J , Satten GA , et al.  HIV Outpatient Study Investigators   Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection . New England Journal of Medicine . 1998;338:853–860
  34. Periard D , Telenti A , Sudre P , Cheseaux JJ , Halfon P , Reymond MJ , et al.   Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors . Circulation . 1999;100:700–705
  35. Pi-Sunyer X , Becker DM , Bouchard C , Carleton RA , Colditz GA , Dietz WH , et al.  National Heart, Lung, and Blood Institute Obesity Education Initiative Task Force   Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults (The evidence report) . Washington, DC: U.S. Department of Health and Human Services; 1998; NIH publication 98-4083
  36. Rhew DC , Bernal M , Aguilar D , Iloeje U , Goetz MB . Association between protease inhibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus (A systematic review) . Clinical Infectious Disease . 2003;7:959–972
  37. Saves M , Raffi F , Capeau J , Rozenbaum W , Ragnaud JM , Perrone C . Factors related to lipodystrophy and metabolic alterations in human immunodeficiency virus infection receiving highly active antiretroviral therapy . Clinical Infectious Disease . 2002;34:1396–1405
  38. Schwarcz SK , Hsu LC , Vittinghoff E , Katz MH . Impact of protease inhibitors and other antiretroviral treatments on acquired immunodeficiency syndrome survival in San Francisco, California, 1987-1996 . American Journal of Epidemiology . 2000;152:178–185
  39. Taylor W , Hepworth J , Lees E , Cassells A , Gousse Y , Sweeney MM , et al.   Readiness to change physical activity and dietary practices and willingness to consult healthcare providers . Health Research Policy and Systems . 2004;2:2
  40. Tershakovec AM , Frank I , Rader D . HIV-related lipodystrophy and related risk factors . Atherosclerosis . 2004;174:1–10
  41. Walker SN , Sechrist KR , Pender NJ . Health Promoting Lifestyle Profile (Development and psychometric characteristics) . Nursing Research . 1987;32:76–81
  42. Walker SN , Sechrist KR , Pender NK . Health Promoting Lifestyle Profile, II . 1995; Omaha, NE: Author.
  43. Walli R , Herfort O , Michl G , Demant T , Jager H , Dieterle C , et al.   Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients . AIDS . 1998;12:F167–F173
  44. Willett W . Anthropometric measures and body composition . In:  Willett W editors. Nutritional Epidemiology . (2nd ed.). New York: Oxford University Press; 1998;p. 244–272
  45. Yeni PG , Hammer SM , Carpenter CC , Cooper DA , Fischl MA , Gatell JM , et al.   Antiretroviral treatment for adult HIV infection in 2002 (Updated recommendations of the International AIDS Society-USA Panel) . Journal of the American Medical Association . 2002;288:222–235

PII: S1055-3290(06)00087-2

doi: 10.1016/j.jana.2006.03.001

Journal of the Association of Nurses in AIDS Care
Volume 17, Issue 3 , Pages 3-17 , May 2006

Article Tools